UTI AMC cancels analyst meeting scheduled on 30 Jun 2026
UTI AMC cancelled its analyst and institutional investor meeting with Avendus Spark scheduled for June 30, 2026, due to an unavoidable travel commitment by Mr. Sanketh Godha, Director of Avendus Spark. The meeting is expected to be rescheduled after the announcement of Q1FY26 results. The disclosure was made under Regulation 30 of the SEBI (LODR) Regulations, 2015, confirming no unpublished price sensitive information was intended to be shared.

*this image is generated using AI for illustrative purposes only.
UTI AMC has cancelled its analyst and institutional investor meeting with Avendus Spark, which was originally scheduled for June 30, 2026, at 4:00 PM IST. The meeting was called off due to an unavoidable travel commitment by Mr. Sanketh Godha, Director, Avendus Spark. The entity has requested to reschedule the interaction at a convenient date after the Q1FY26 results are announced.
The disclosure was made pursuant to Regulation 30 read with Schedule III Part A Para A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company clarified that no unpublished price sensitive information (UPSI) would have been shared during the session.
The details of the cancelled meeting are as follows:
| Date & Time | Name | Mode of the Meeting | Place |
|---|---|---|---|
| 30 June, 2026 at 1600 hrs IST | Avendus Spark | In person | Corporate Office, BKC, Mumbai |
Arvind Bhagwan Das Patkar, Company Secretary and Compliance Officer of UTI Asset Management Company Limited, signed the disclosure regarding the cancellation.
Historical Stock Returns for UTI AMC
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.21% | +3.89% | +6.30% | -14.44% | -25.73% | +14.71% |
How might the delay in the interaction with Avendus Spark affect institutional investor sentiment ahead of the Q1FY26 results?
What specific topics or strategic updates were likely prioritized for discussion with Avendus Spark that investors should now anticipate in the post-earnings call?
Could the rescheduling of this meeting indicate a broader trend of management unavailability or travel constraints that might impact future investor relations?






























